great run today...but now overvalued at $33M. $100K profit...can’t easily turn into $M in this type of business. Revenue didn’t grow from H2 2018.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game